Next-Generation Ocular Genomics

See Genetic Eye Disease Before It Affects Vision Advanced Genetic Testing for Hereditary Eye Disorders

Ophthalmic abstract genomic vision flow visual

Gene Coverage

86 Vision-Related Genes

Turnaround

7–10 Days

Genetic testing reveals inherited mutations responsible for retinal, optic nerve, and structural eye disorders—enabling earlier diagnosis, precise treatment, and long-term vision preservation.

86-Gene Eye Disorder Panel
7–10 Day Turnaround
Buccal Swab / Saliva Sample
Clinical Risk Stratification
Precision Ophthalmic Reporting

Precision Retina Imaging

Advanced genomic sequencing evaluates all 86 vision pathways, identifying pathogenic variants prior to functional vision loss.

86

Total Genes

>96%

Read Exons

Revolutionizing Vision Care

The Power of Genetic Testing in
Understanding & Treating Eye Disorders

In the realm of healthcare, advancements in genetic testing have revolutionized the way we diagnose and treat various medical conditions. When it comes to eye disorders, genetic testing has emerged as a powerful tool, offering new insights into the underlying causes and paving the way for personalized treatment strategies.

Eye disorders encompass a wide range of conditions, including inherited diseases, age-related degeneration, refractive errors, and more. Historically, diagnosing eye disorders relied on clinical observations and physical examinations. While these methods have been valuable, they often fall short in uncovering the genetic components that play a significant role in many ocular conditions.

0%
Over 60% of childhood blindness is genetic
0%
Many structural eye defects are inherited
0%
Early genetic identification preserves retina health
0%
Guides family-wide screening strategies
Clinical Value

Hereditary Ocular Testing Benefits

Genetic testing for hereditary eye disorders provides several critical benefits for physicians and patients:

Early Detection

Genetic testing allows for the early identification of eye disorders, even before symptoms manifest. This early detection empowers healthcare professionals to intervene proactively, potentially preventing or delaying the onset of vision loss.

Accurate Diagnosis

Eye disorders can exhibit overlapping symptoms, making it challenging to arrive at an accurate diagnosis based on clinical presentation alone. Genetic testing helps differentiate between similar conditions, enabling tailored treatment plans and improved patient outcomes.

Tailored Treatment Strategies

Genetic testing provides critical information about the specific genetic mutations associated with an individual's eye disorder. Armed with this knowledge, healthcare professionals can personalize treatment plans, selecting interventions that target the underlying causes rather than merely managing symptoms.

Familial Screening

Many eye disorders have a hereditary component, meaning they can be passed down through generations. Genetic testing enables the identification of at-risk family members, facilitating early screening and preventive measures to protect their vision.

Research and Development

Genetic testing plays a vital role in advancing our understanding of eye disorders. By collecting genetic data from individuals with various eye conditions, scientists can uncover new genetic markers, paving the way for the development of novel treatments and interventions.

Vision Preservation

Enables clinicians to monitor patients at risk with high frequency, establishing baselines and deploying protective clinical aids before retinal photoreceptor cells degrade irrecoverably.

Core Pathology Scope

Diseases & Conditions Related to Hereditary Eye Genes

Our comprehensive sequencing pipeline tests for mutations responsible for retinal degenerations, optic nerve conditions, and structural eye defects.

Retinitis Pigmentosa (RP)

RP is a group of inherited retinal disorders characterized by progressive degeneration of the retina. Genetic mutations in several genes, including RPGR, RHO and PRPF31, among others, have been associated with different forms of RP.

Target GenesRPGR, RHO, PRPF31

Leber Congenital Amaurosis (LCA)

LCA is a rare inherited disorder that affects the retina, leading to severe visual impairment or blindness in infancy. Mutations in genes such as RPE65 have been implicated in LCA.

Target GenesRPE65, GUCY2D, AIPL1

Age-Related Macular Degeneration (AMD)

AMD is a common cause of vision loss in older adults. While age and environmental factors contribute to AMD, genetic variations in genes like CFH have been identified as significant risk factors for the disease.

Target GenesCFH, ARMS2, C3

Glaucoma

Glaucoma encompasses a group of eye conditions that damage the optic nerve, leading to progressive vision loss. Mutations in genes such as MYOC and CYP1B1 have been linked to specific forms of glaucoma.

Target GenesMYOC, CYP1B1, OPTN

Congenital Cataracts

Congenital cataracts refer to the presence of clouding in the lens of the eye at birth or early infancy. Several genetic mutations, including those in genes like CRYAA and HSF4 have been associated with different types of congenital cataracts.

Target GenesCRYAA, HSF4, GJA3

Usher Syndrome

Usher syndrome is a genetic disorder characterized by both hearing loss and visual impairment. Multiple genes, including MYO7A, USH2A, and CDH23, have been implicated in different subtypes of Usher syndrome.

Target GenesMYO7A, USH2A, CDH23
Provider Value

Why Eye Specialists Use Genetic Testing

01

Diagnostic Clarity

Resolve ambiguous retinal disease diagnoses.

02

Treatment Guidance

Enable gene-based therapy selection.

03

Early Intervention

Prevent irreversible vision loss progression.

04

Family Risk Mapping

Identify hereditary ocular conditions.

05

Clinical Support

Improve ophthalmology treatment planning.

Genomic Registry

Comprehensive 86-Gene Panel

Covers genes associated with retinal dystrophies, optic nerve disorders, corneal diseases, congenital lens abnormalities, and syndromic vision loss.

ACMG-Validated Gene Set

Vision Gene Explorer

Our panel sequencing targets molecular elements linked to Leber Congenital Amaurosis, Retinitis Pigmentosa, Usher Syndrome, and congenital cataracts.

RHO
RPGR
RPE65
MYOC
PAX6
CFH
USH2A
CRYAA

View Full 86-Gene Index

Search individual ophthalmic genes or explore the complete list of targeted genetic elements.

Clinical Pathway

How Eye Genetic Testing Works

01

Clinical Eye Assessment

Ophthalmic history evaluation.

02

Sample Collection

Simple saliva or buccal swab.

03

NGS Sequencing

Ocular disorder gene analysis.

04

Variant Interpretation

Pathogenic classification.

05

Clinical Reporting

Vision risk + treatment guidance.

Risk Assessment

Is Eye Genetic Testing Right for You?

Clinical guidelines recommend testing for patients exhibiting specific family or diagnostic indicator histories.

Diagnostic Indicator

Family history of vision loss

Diagnostic Indicator

Early onset eye disease

Diagnostic Indicator

Unexplained retinal changes

Diagnostic Indicator

Progressive night blindness

Diagnostic Indicator

Congenital vision abnormalities

Diagnostic Indicator

Suspected inherited eye disorder

Lab Standards

Test Specifications

Acceptable sample requirements

Buccal Swab or Saliva

Turnaround time

7-10 Business days

Gene panel

86 Curated Exons

Testing Method

Next Generation Sequencing (NGS)

Reporting

Likely pathogenic and Pathogenic variants

Coverage

>96% Coverage at 20x Depth

Customization

Customizable Gene List Available

Unlocking the Secrets of Your Genetic Health

Comprehensive Genetic Testing at Preventive Genomics

Preventive Genomics is a premier choice for clinicians seeking accurate genomic insights for several reasons:

HIGH-QUALITY TESTING

Preventive Genomics uses advanced technology and has experienced technicians to ensure that the testing is performed to the highest standards.

FAST TURNAROUND TIME

Preventive Genomics has a fast turn around time for test results. This means that doctors can quickly get the information they need to make informed decisions about their patients' treatment.

COMPREHENSIVE OPTIONS

We offer a wide range of genetic testing options, including tests for Diabetes predict, Cancer genetics, Cardiovascular, Drug-Gene Interactions and Neurological disorders.

COLLABORATIVE APPROACH

Preventive Genomics works closely with doctors to ensure that the testing is tailored to the specific needs of each patient. They provide personalized support and guidance throughout.

Patient roadmap to better health

Decoding the Mystery of Genetic Testing

Genetic testing is a medical test that examines your DNA to identify any changes or mutations that may be associated with a specific disease or condition. This guide aims to provide you with an overview of genetic testing, its significance, outcomes, and family health benefits.

Navigation Guide

Insurance Coverage

If you are considering genetic testing, it is important to check with your health insurance provider to determine your coverage.

Genomic Core

What is Genetic Testing?

DNA is the genetic material that contains the instructions for the development, growth, and function of all living organisms. Genetic testing can provide information about inherited diseases or conditions, predispositions to certain diseases, and the likelihood of passing these conditions onto your children.

Preventive Genomics Educational Series HIPAA Compliant
Insurance Verification Process

Confirming Coverage Prior to Testing

Check with your health insurance provider to determine your coverage. You can complete this verification step through three actions:

1. Review Policy

Contact insurance to check coverage conditions.

2. Consult Provider

Confirm medical necessity credentials.

3. Prior Auth

Submit diagnostic requests for pre-approval.

VDiagnostics Ophthalmic v4.8
NGS_EYE_V1
PATIENT NAME: Jenkins, Sarah
SPECIMEN ID: #EY-4903-NGS
DOB: 10/12/1977
REFERRING MD: Dr. L. Vance
Sequencing Result Summary▲ PATHOGENIC DETECTED
GENE: RPE65c.882T>G (p.Tyr294*)
ZYGOSITY: Homozygous | VARIANT CLASSIFICATION: Pathogenic
Associated Phenotype: Leber Congenital Amaurosis / Retinal Dystrophy
Ophthalmic Action Plan
Evaluate for FDA-approved RPE65 gene therapy
Schedule goldman visual field examination
Initiate cascade testing for sibling carriers
Authorized by Lab DirectorREPORT SIGNED
Provider Action Protocol

What to do when genetic testing
comes back positive

If a doctor receives a positive report for the genetic testing of hereditary eye disorders, there are several next steps they may take:

1

Confirming the diagnosis

If a genetic mutation is identified, doctors may confirm the diagnosis through further testing or clinical evaluation to determine the extent of the disease or condition.

2

Inform the patient and family

The doctor will inform the patient and their family members of the diagnosis and the implications of the genetic test results. They will also discuss the possibility of genetic counseling.

3

Develop a treatment plan

The doctor will develop a treatment plan tailored to the specific disorder and the patient's individual needs. This may include medications, therapies, and lifestyle changes.

4

Monitor the patient

The doctor will monitor the patient's condition over time to ensure that the treatment plan is effective and to adjust it as necessary.

5

Offer genetic counseling

The doctor may refer the patient and their family members to a genetic counselor to discuss the risk of passing on the disorder to future generations and options for family planning.

Responsible Practice

Ethical Considerations

While the benefits of genetic testing for eye disorders are undeniable, it is crucial to address the ethical implications associated with this practice. Protecting patient privacy, ensuring informed consent, and providing counseling services to help individuals understand and cope with their results are essential aspects of responsible genetic testing.

Patient Privacy Protection
Informed Consent Protocols
Clinical Counseling Services
Patient Education Hub

Frequently Asked Questions

Protect Vision Through
Genetic Intelligence

Identify inherited eye disease risk early and enable precision ophthalmic care that preserves vision across generations.